Questcor Pharmaceuticals (QCOR) 80.75 $QCOR
Questcor Buyout Shocks Short Sellers
Keith Speights, The Motley Fool - Motley Fool - 1 hr 3 mins ago
Activist short seller Andrew Left's Citron Research frequently uses the phrase: "It's never a problem until it's a problem." Monday's news about specialty pharmaceutical firm Mallinckrodt 's acquisition of Questcor Pharmaceuticals put a new...
QUESTCOR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Business Wire - 2 hrs 13 mins ago
Rigrodsky & Long, P.A.:
Mallinckrodt to Acquire Questcor - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 18 mins ago
Shares of Questcor Pharmaceuticals were up 18.7% after Dublin-based specialty pharmaceutical company Mallinckrodt announced that it has entered into a definitive agreement to acquire the former for $5.6 billion.
Roche Acquires IQuum - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 58 mins ago
In order to strengthen its diagnostics business, Roche announced that it has acquired privately held IQuum, Inc. for $275 million in upfront cash.
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Questcor Pharmaceuticals, Inc. - QCOR
PR Newswire - Tue Apr 08, 1:10PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Questcor Pharmaceuticals, Inc. ("Questcor" or the "Company") (Nasdaq: QCOR) relating to the proposed acquisition by Mallinckrodt plc ("Mallinckrodt").
INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of Questcor Pharmaceuticals, Inc. and Its Board of Directors In Connection With the Sale of the Company to Mallinckrodt
Business Wire - Tue Apr 08, 11:18AM CDT
Levi & Korsinsky is investigating the Board of Directors of Questcor Pharmaceuticals Inc. ("Questcor" or "the Company") (NasdaqGS: QCOR) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Mallinckrodt.
Jim Cramer: In the Abstract, the Shorts May Be Right
at The Street - Tue Apr 08, 10:19AM CDT
But in the real world they're wrong, as the Questcor buyout demonstrates.
Jim Cramer's Mad Dash: QCOR MNK
at The Street - Tue Apr 08, 9:42AM CDT
Investors don't know what to make of Mallinckrodt's planned acquisition of Questcor, Cramer says.
Company News for April 08, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 9:06AM CDT
Companies in the News are: QCOR,MNK,GAS,MNKD,PBR
Mallinckrodt plc Takes a Big Swing for Growth
Stephen D., Simpson,, The Motley Fool - Motley Fool - Tue Apr 08, 8:30AM CDT
Facing declining market share in its core generic controlled substance (painkillers) market and holding the valuable asset of an Irish tax domicile, Mallinckrodt plc has aggressively put its balance sheet to work. First the company...
Questcor Pharmaceuticals (QCOR) Shows Strength: Stock Surges 18.7% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 7:44AM CDT
Questcor Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares shoot up nearly 19% on the day.
Myriad, Tata Motors Among RS Leaders In Correction
at Investor's Business Daily - Tue Apr 08, 7:02AM CDT
The market is in a correction and growth stocks are taking the biggest hit. But just because a company's stock is falling doesn't mean it isn't still a leader. Smart investors should be on the lookout for companies whose Relative Strength lines are...
Questcor Pharmaceuticals' board to pay USD0.30 per share dividend
M2 - Tue Apr 08, 6:04AM CDT
The board of directors of Questcor Pharmaceuticals (NasdaqGS:QCOR), a biopharmaceutical company, on Monday declared its quarterly dividend of USD0.30 per share of its stock.
Jim Cramer's Top Stock Picks: FSLR NFLX AMZN TSLA PCLN
at The Street - Tue Apr 08, 5:00AM CDT
Priceline is Cramer's favorite in the over $500 a share category while First Solar is best of breed and very inexpensive.
Questcor Pharmaceuticals to be Bought by Mallinckrodt; Sprint to offer Windows Phone 8.1 Upgrade on the HTC 8XT and Samsung's ATIV S Neo
ACCESSWIRE - Tue Apr 08, 12:06AM CDT
Oracle Corporation (NYSE: ORCL) - For an in-depth report on Oracle Corporation follow: www.BullTrends.com/stockquote/ORCL
Mallinckrodt to Buy Drugmaker Questcor Pharmaceuticals for about $5.6B; Tesla Rated "Outperform" by RW Baird
ACCESSWIRE - Tue Apr 08, 12:00AM CDT
Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) - For an in-depth report on Ariad Pharmaceuticals Inc. follow: www.BullTrends.com/stockquote/ARIA
Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
PR Newswire - Mon Apr 07, 7:30PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Questcor Pharmaceuticals, Inc. ("Questcor" or the "Company") (NASDAQ: QCOR) concerning the proposed acquisition of the Company by private equity firm Mallinckrodt Plc.
QUESTCOR INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Questcor Pharmaceuticals Inc. (QCOR) Over the Proposed Sale of the Company to Mallinckrodt plc (MNK)
Business Wire - Mon Apr 07, 7:15PM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Questcor Pharmaceuticals Inc. ("Questcor" or the "Company") (Nasdaq: QCOR) for potential breaches of fiduciary duties in connection with the sale of the Company to Mallinckrodt plc for approximately $5.2 billion. The Company's stockholders will receive $30.00 cash and 0.897 Mallinckrodt shares for each share of Questcor common stock they own.
Jim Cramer's 'Mad Money' Recap: Where's the Rally?
at The Street - Mon Apr 07, 7:13PM CDT
Cramer says the economy may be getting better but the markets sure aren't showing it.
Acquisition of Questcor Pharmaceuticals, Inc. by Mallinckrodt plc May Not Be in Shareholders' Best Interests
PR Newswire - Mon Apr 07, 6:54PM CDT
Shareholder rights attorneys at Robbins Arroyo LLP is investigating the proposed acquisition of Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) by Mallinckrodt plc (NYSE: MNK). On April 7, 2014, the two companies announced the signing of a definitive merger agreement pursuant to which Questcor shareholders will receive $30.00 per share in cash and 0.897 Mallinckrodt shares for each for each share of Questcor common stock, for a total consideration of $86.10 per share.
Questcor Buyout Shocks Short Sellers
Keith Speights, The Motley Fool - Motley Fool - 1 hr 3 mins ago
Activist short seller Andrew Left's Citron Research frequently uses the phrase: "It's never a problem until it's a problem." Monday's news about specialty pharmaceutical firm Mallinckrodt 's acquisition of Questcor Pharmaceuticals put a new...
QUESTCOR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Business Wire - 2 hrs 13 mins ago
Rigrodsky & Long, P.A.:
Mallinckrodt to Acquire Questcor - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 18 mins ago
Shares of Questcor Pharmaceuticals were up 18.7% after Dublin-based specialty pharmaceutical company Mallinckrodt announced that it has entered into a definitive agreement to acquire the former for $5.6 billion.
Roche Acquires IQuum - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 58 mins ago
In order to strengthen its diagnostics business, Roche announced that it has acquired privately held IQuum, Inc. for $275 million in upfront cash.
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Questcor Pharmaceuticals, Inc. - QCOR
PR Newswire - Tue Apr 08, 1:10PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Questcor Pharmaceuticals, Inc. ("Questcor" or the "Company") (Nasdaq: QCOR) relating to the proposed acquisition by Mallinckrodt plc ("Mallinckrodt").
INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of Questcor Pharmaceuticals, Inc. and Its Board of Directors In Connection With the Sale of the Company to Mallinckrodt
Business Wire - Tue Apr 08, 11:18AM CDT
Levi & Korsinsky is investigating the Board of Directors of Questcor Pharmaceuticals Inc. ("Questcor" or "the Company") (NasdaqGS: QCOR) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Mallinckrodt.
Jim Cramer: In the Abstract, the Shorts May Be Right
at The Street - Tue Apr 08, 10:19AM CDT
But in the real world they're wrong, as the Questcor buyout demonstrates.
Jim Cramer's Mad Dash: QCOR MNK
at The Street - Tue Apr 08, 9:42AM CDT
Investors don't know what to make of Mallinckrodt's planned acquisition of Questcor, Cramer says.
Company News for April 08, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 9:06AM CDT
Companies in the News are: QCOR,MNK,GAS,MNKD,PBR
Mallinckrodt plc Takes a Big Swing for Growth
Stephen D., Simpson,, The Motley Fool - Motley Fool - Tue Apr 08, 8:30AM CDT
Facing declining market share in its core generic controlled substance (painkillers) market and holding the valuable asset of an Irish tax domicile, Mallinckrodt plc has aggressively put its balance sheet to work. First the company...
Questcor Pharmaceuticals (QCOR) Shows Strength: Stock Surges 18.7% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 7:44AM CDT
Questcor Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares shoot up nearly 19% on the day.
Myriad, Tata Motors Among RS Leaders In Correction
at Investor's Business Daily - Tue Apr 08, 7:02AM CDT
The market is in a correction and growth stocks are taking the biggest hit. But just because a company's stock is falling doesn't mean it isn't still a leader. Smart investors should be on the lookout for companies whose Relative Strength lines are...
Questcor Pharmaceuticals' board to pay USD0.30 per share dividend
M2 - Tue Apr 08, 6:04AM CDT
The board of directors of Questcor Pharmaceuticals (NasdaqGS:QCOR), a biopharmaceutical company, on Monday declared its quarterly dividend of USD0.30 per share of its stock.
Jim Cramer's Top Stock Picks: FSLR NFLX AMZN TSLA PCLN
at The Street - Tue Apr 08, 5:00AM CDT
Priceline is Cramer's favorite in the over $500 a share category while First Solar is best of breed and very inexpensive.
Questcor Pharmaceuticals to be Bought by Mallinckrodt; Sprint to offer Windows Phone 8.1 Upgrade on the HTC 8XT and Samsung's ATIV S Neo
ACCESSWIRE - Tue Apr 08, 12:06AM CDT
Oracle Corporation (NYSE: ORCL) - For an in-depth report on Oracle Corporation follow: www.BullTrends.com/stockquote/ORCL
Mallinckrodt to Buy Drugmaker Questcor Pharmaceuticals for about $5.6B; Tesla Rated "Outperform" by RW Baird
ACCESSWIRE - Tue Apr 08, 12:00AM CDT
Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) - For an in-depth report on Ariad Pharmaceuticals Inc. follow: www.BullTrends.com/stockquote/ARIA
Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
PR Newswire - Mon Apr 07, 7:30PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Questcor Pharmaceuticals, Inc. ("Questcor" or the "Company") (NASDAQ: QCOR) concerning the proposed acquisition of the Company by private equity firm Mallinckrodt Plc.
QUESTCOR INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Questcor Pharmaceuticals Inc. (QCOR) Over the Proposed Sale of the Company to Mallinckrodt plc (MNK)
Business Wire - Mon Apr 07, 7:15PM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Questcor Pharmaceuticals Inc. ("Questcor" or the "Company") (Nasdaq: QCOR) for potential breaches of fiduciary duties in connection with the sale of the Company to Mallinckrodt plc for approximately $5.2 billion. The Company's stockholders will receive $30.00 cash and 0.897 Mallinckrodt shares for each share of Questcor common stock they own.
Jim Cramer's 'Mad Money' Recap: Where's the Rally?
at The Street - Mon Apr 07, 7:13PM CDT
Cramer says the economy may be getting better but the markets sure aren't showing it.
Acquisition of Questcor Pharmaceuticals, Inc. by Mallinckrodt plc May Not Be in Shareholders' Best Interests
PR Newswire - Mon Apr 07, 6:54PM CDT
Shareholder rights attorneys at Robbins Arroyo LLP is investigating the proposed acquisition of Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) by Mallinckrodt plc (NYSE: MNK). On April 7, 2014, the two companies announced the signing of a definitive merger agreement pursuant to which Questcor shareholders will receive $30.00 per share in cash and 0.897 Mallinckrodt shares for each for each share of Questcor common stock, for a total consideration of $86.10 per share.
